medical imaging device News
-
MEDICA 2019, Messe Dusseldorf. Hall 11/F55
Biomedicinos Technika took part in the MEDICA 2019 tradefair in Dusseldorf! We demonstrated colposcopes SLV-101 HD, SLV - 101 and ALScope HD at our booth. Also prototypes promising colposcope SLV-101-mini and Medical Imaging Workstation were shown. SLV-101-mini is the project of Ready-to-use full HD videocolposcope. Medical Imaging Workstation is a device for archiving medical photos and ...
-
C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray’s Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer
C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American: ISR) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of C4 Imaging’s Sirius positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray’s Cesium-131, brachytherapy seeds. Sirius is implanted during the treatment of prostate cancer with brachytherapy and is used ...
By Isoray Inc.
-
InHealth (North and East Devon NHS Breast Screening Unit) signing up to the AI in Health & Care Award with Kheiron Medical Technologies
InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in Health & Care Award. This partnership marks another significant step in the journey to build an evidence base to demonstrate the effectiveness and safety of artificial intelligence in NHS breast cancer screening. ...
-
Complete Response Letter received from FDA
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with an investigational drug-device combination product using hyperpolarised xenon-129 gas to enhance magnetic resonance imaging (MRI) in pulmonary medicine, announces that the Company has received a Complete Response Letter (“CRL”) from the U.S. Food and Drug Administration (“FDA”) for the New Drug ...
-
Polarean Announces NDA Submission of 129 Xenon Gas MRI
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with an investigational drug-device combination product for magnetic resonance imaging (MRI), announces its submission of a New Drug Application (“NDA”) and request for priority review to the US Food and Drug Administration (“FDA”) for hyperpolarized 129Xenon gas used to evaluate pulmonary ...
-
OnLume Surgical Completes $7 Million Series A Financing
OnLume Surgical, a Wisconsin-based medical device company developing novel imaging systems for use during surgery, announced the completion of its Series A funding to assist its plans for commercial launch. OnLume raised over $7 Million in this financing, adding to a $2 Million Phase II SBIR grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH), awarded in ...
By OnLume Inc.
-
New View Surgical, Inc. Recognized as ‘Most Valued Company’ at virtual Keiretsu Forum Investor Capital Expo
New View Surgical, Inc. an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery, was recognized as one of the top three ‘Most Valued Company’ at the Keiretsu Forum Investor Capital Expo that is showcasing 36 late-stage growth companies seeking funding. Nearly 50 angel groups, investors from 100+ Family Offices, corporate ...
-
New View Surgical, Inc. Announces FDA Clearance of its VisionPort™ System for Minimally Invasive Surgery
New View Surgical, Inc., a medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration for its VisionPort™ System. The VisionPort™ imaging and access system simplifies laparoscopic procedures for hospitals and provides surgeon-controlled ...
-
Fluidda and Aptar Pharma Exclusive Collaboration
Fluidda, leader in the field of Functional Respiratory Imaging and developer of the medical device Broncholab®, today announced an exclusive collaboration with Nanopharm, an Aptar Pharma company and a leader in contract research and development services for orally inhaled and nasal drug products (OINDPs). The companies will leverage their respective proprietary technology platforms to help ...
By Fluidda
-
New View Surgical, Inc. Closes Series A Round of Financing
New View Surgical, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery, announced that it closed its Series A Financing Round at $2.5 million. The financing was over-subscribed due to investor demand. New View Surgical will deploy the financing to complete the development of its VisionPort™ System, expand the ...
-
GE Healthcare in collaboration with Nex Cubed select six digital health start-ups for inaugural Edison Accelerator in Canada
Six digital health start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program designed by GE Healthcare and delivered in collaboration with Nex Cubed to accelerate, validate, and scale innovative solutions that address important challenges in the healthcare sector. The companies all focus on applying Artificial Intelligence (AI) to ...
-
Robocath successfully completes first robotic coronary angioplasty with R-One in China
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One™ robotic platform. The procedure took place at the 301 Hospital in Beijing on November 24; performed by Dr. Yundai Chen, a renowned interventional ...
By Robocath
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you